Avadel Pharmaceuticals plc (NASDAQ: AVDL) Stock Information | RedChip

Avadel Pharmaceuticals plc (NASDAQ: AVDL)


$10.4400
+0.3300 ( +4.51% ) 460.1K

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

Market Data


Open


$10.4400

Previous close


$10.1100

Volume


460.1K

Market cap


$980.48M

Day range


$10.0000 - $10.5190

52 week range


$9.4100 - $19.0900

SEC Filings


Form Type Description Pages Date
8-k 8K-related 15 May 21, 2024
10-q Quarterly Reports 68 May 08, 2024
8-k 8K-related 15 May 08, 2024
8-k 8K-related 14 May 08, 2024
3 Insider transactions 2 May 03, 2024
10-k/a Quarterly Reports 13 Apr 26, 2024
8-k 8K-related 13 Apr 15, 2024
8-k 8K-related 16 Mar 04, 2024
8-k 8K-related 14 Mar 04, 2024
4 Insider transactions 1 Mar 04, 2024

Latest News